These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34169154)

  • 1. Central Nervous System Tuberculosis (CNS-TB) in treated HIV-infected adults in Tikur Anbessa Specialized Hospital, Ethiopia: A cross sectional study.
    Ayele BA; Amogne W
    J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100252. PubMed ID: 34169154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV screening among TB patients and level of antiretroviral therapy and co-trimoxazole preventive therapy for TB/HIV patients in Hawassa University Referral Hospital: a five year retrospective study.
    Simieneh A; Hailemariam M; Amsalu A
    Pan Afr Med J; 2017; 28():75. PubMed ID: 29255545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Outcomes of Tuberculosis and Associated Factors Among Tuberculosis and Human Immunodeficiency Virus Co-infected Patients in Public Health Facilities in Jigjiga, Somali Region, Ethiopia.
    Abdilahi AO; Ahmed AA; Osman MO
    Cureus; 2024 Mar; 16(3):e56092. PubMed ID: 38618401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
    Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
    Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Survival Time to Death Among TB and HIV Co-infected Adult Patients: an Institution-Based Retrospective Cohort Study.
    Lelisho ME; Teshale BM; Tareke SA; Hassen SS; Andargie SA; Merera AM; Awoke S
    J Racial Ethn Health Disparities; 2023 Aug; 10(4):1616-1628. PubMed ID: 35697902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of tuberculosis among HIV patients after initiation of antiretroviral treatment in Ethiopia: a systematic review and meta-analysis.
    Azanaw MM; Derseh NM; Yetemegn GS; Angaw DA
    Trop Med Health; 2021 Feb; 49(1):18. PubMed ID: 33632342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis.
    Navarro-Flores A; Fernandez-Chinguel JE; Pacheco-Barrios N; Soriano-Moreno DR; Pacheco-Barrios K
    J Neurol; 2022 Jul; 269(7):3482-3494. PubMed ID: 35288778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study.
    Ali SA; Mavundla TR; Fantu R; Awoke T
    BMC Infect Dis; 2016 Nov; 16(1):640. PubMed ID: 27814693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active TB infection and its associated factors among HIV-1 infected patients at Jimma medical center, Southwest Ethiopia.
    Mulugeta T; Takale A; Umeta B; Terefe B
    J Pharm Health Care Sci; 2021 Dec; 7(1):44. PubMed ID: 34865659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
    Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
    BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.